STOCK TITAN

FTRE (FTRE) holder plans 1,179-share Rule 144 stock sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of FTRE common stock filed a notice of proposed sale under Rule 144. The filing covers up to 1,179 common shares, with an aggregate market value of 16,367.11, to be sold through Fidelity Brokerage Services on the NASDAQ, with an approximate sale date of 02/10/2026. The shares were acquired on 02/09/2026 through restricted stock vesting from the issuer as compensation. The filing notes that total common shares outstanding are 92,400,000, which is a baseline figure and not the amount being sold.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the FTRE Form 144 filing disclose?

The Form 144 filing for FTRE discloses a planned sale of 1,179 common shares under Rule 144. These shares, valued at about 16,367.11, are intended to be sold on the NASDAQ through Fidelity Brokerage Services on or about 02/10/2026.

How many FTRE shares are planned to be sold and what is their value?

The filing shows a planned sale of 1,179 FTRE common shares with an aggregate market value of about 16,367.11. The transaction is to be executed through Fidelity Brokerage Services LLC on the NASDAQ, according to the disclosed Rule 144 notice.

When and how were the FTRE shares in this Form 144 acquired?

The 1,179 FTRE common shares were acquired on 02/09/2026 via restricted stock vesting from the issuer. The filing identifies the nature of the acquisition as compensation, with payment dated the same day, indicating these shares arose from an equity compensation award.

What is the approximate sale date and trading venue for the FTRE shares?

The planned sale date for the FTRE shares is approximately 02/10/2026. The filing states the common stock is expected to be sold on the NASDAQ securities exchange, using Fidelity Brokerage Services LLC as the broker handling the transaction under Rule 144.

How many FTRE shares are outstanding compared with the amount to be sold?

The Form 144 notes 92,400,000 FTRE common shares outstanding, while only 1,179 shares are covered by this proposed sale. The outstanding figure provides scale for the issuer’s equity base, whereas the filing concerns a much smaller portion.

What type of transaction underlies the FTRE Form 144 sale?

The FTRE Form 144 sale is based on shares received through restricted stock vesting from the issuer. The filing classifies the nature of payment as compensation, meaning the seller earned the 1,179 shares as part of an equity compensation arrangement rather than a cash purchase.
Fortrea Holdings

NASDAQ:FTRE

FTRE Rankings

FTRE Latest News

FTRE Latest SEC Filings

FTRE Stock Data

1.37B
91.88M
0.5%
111.46%
11.57%
Biotechnology
Services-medical Laboratories
Link
United States
DURHAM